SignatureFD’s Jade Biosciences JBIO Stock Holding History

SignatureFD’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.3K	Hold	732	–	–	﹤0.01%	2436
2026 Q1	$10.3K	Buy	732 +604	+472%	+$8.75K	﹤0.01%	2500
2025 Q4	$1.98K	Buy	+128	New	+$1.5K	﹤0.01%	2974

Other funds holding JBIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SignatureFD's JBIO Position: Q2 2026 in Review

SignatureFD held its Jade Biosciences (JBIO) position steady in Q2 2026 at 732 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2436.

SignatureFD first reported a position in JBIO in Q4 2025 and has held it in 3 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

SignatureFD held 732 shares of Jade Biosciences worth $16.3K as of Q2 2026.
SignatureFD left its Jade Biosciences share count unchanged in Q2 2026.
Jade Biosciences made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2436 holding.
SignatureFD first reported a position in Jade Biosciences in Q4 2025 and has held it in 3 quarters since.
154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.